Agoracom Blog Home

Posts Tagged ‘#HTIM’

CLIENT FEATURE: Applied Biosciences $APPB Investment in JUUL Labs Paying Dividends for Shareholders $HTIM $JUUL $WMD

Posted by AGORACOM at 10:19 AM on Wednesday, February 6th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL)
  • The investment remains on the balance sheet under Equity Investments, the company has begun a strategic review of options for the remaining equity stake. 
  • Altria Group Inc. (NYSE: MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion.
  • APPB also recently acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company with proven revenues
  • Applied BioSciences early stage investment in Hightimes Magazine is valued at approximately $1.75 Million at assumed IPO Pricing of $11.00
  • APPB has a market cap of $15m US & 10m S/O

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com. 

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , , ,
Posted in Applied BioSciences | Comments Off on CLIENT FEATURE: Applied Biosciences $APPB Investment in JUUL Labs Paying Dividends for Shareholders $HTIM $JUUL $WMD

Applied Biosciences $APPB Receives Distribution from Investment in JUUL Labs $HTIM $WMD $JUUL

Posted by AGORACOM at 11:28 AM on Tuesday, February 5th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Received a capital distribution of approximately $186,000 from its investment in JUUL Labs
  • Altria Group Inc. (NYSE: MO) invested $12.8bn in vaping company Juul Labs, a (35% stake) valuing JUUL at $38 billion
  • The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024
  • APPB has a market cap of $15m US & 10m S/O

LOS ANGELES, Feb. 05, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that has received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL).   The company has made strategic investments in select companies they believed to be innovators in the consumer space.  The investment remains on the balance sheet under Equity Investments, but the company has begun a strategic review of options for the remaining equity stake. 

Altria Group Inc. (NYSE: MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion.  Howard Willard, Altria’s CEO said in a statement that the move was an effort to “prepare for a future where adult smokers overwhelmingly choose non-combustible products over cigarettes.” 

JUUL has become a success story and one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years.  Their brand has become synonymous with vaping and the e-cigarette market. 

The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024, according to Research Nestor (www.researchnester.com).

The company continues to make select investments in companies that can help shape the product roadmap and development of new products and potential partnerships.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com. 

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Tags: , , , , , , , , ,
Posted in Applied BioSciences | Comments Off on Applied Biosciences $APPB Receives Distribution from Investment in JUUL Labs $HTIM $WMD $JUUL

$APPB Applied BioSciences Launches Expanded Pet Line Under Herbal Pet $HTIM

Posted by AGORACOM at 11:56 AM on Tuesday, October 9th, 2018

 

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Expanded and launched a hemp derived CBD pet line under the Herbal Pet brand
  • In addition to CBD, the chews contain several important ingredients that promote good health.
  • Applied BioSciences continues to be at the forefront of the cannabinoid market, using organically grown plants, without pesticides or herbicides
  • The products will be sold on Herbal Pet’s new website (http://www.herbalpet.com)

Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has expanded and launched a hemp derived CBD pet line under the Herbal Pet brand. The products will be sold on Herbal Pet’s new website (http://www.herbalpet.com) and in select locations in the U.S.

Although the health benefits of CBD are now considered well known, one of the challenges of working with CBD is its bitter after taste. Applied Biosciences focused on this common feedback from humans and developed formulations to improve the experience for both humans and pets. Aromas from CBD are strong and to a dog, that level of concentration can be displeasing. To overcome this issue, the product line (including our chews) has been specifically formulated with natural, high protein, human grade chicken meat – our number 1 ingredient.

In addition to CBD, these chews contain several important ingredients that promote good health. The calming support chew consists of super foods (sweet potato and turmeric) as well as antioxidants (organic chamomile) and a natural amino acid (L-Theanine). The mobility support chew also has bone broth, glucosamine, and chondroitin for bone health. It is also grain-free. Importantly, these products contain no synthetic preservatives, no fillers, no Genetically Engineered ingredients (GMO) and no animal feed ingredients.

“Applied BioSciences continues to be at the forefront of the cannabinoid market, first using organically grown plants, without pesticides or herbicides as our main ingredient and now quickly and easily providing consumers with a variety of tinctures, topical creams and alternatives to the growing demand of this space. Our company continues to launch our product lines in select specialty and retail stores, people and pet owners will also be able to visit our websites to find holistic health and wellness alternatives that best suit their lifestyle,” commented Chris Bridges, President of Applied BioSciences Corp.

Applied BioSciences products are USDA-NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC- free. Our products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanicals, herbals and essential oils to further optimize bioavailability.

About Applied BioSciences Corp.
Applied BioSciences Corp. (http://www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact
Email: ir(at)appliedbiocorp.com or info(at)appliedbiocorp.com

To be added to the Applied BioSciences email distribution list, please email info(at)appliedbiocorp.com with APPB in the subject line.

Official Website:
http://www.appliedbiocorp.com

Brands:
http://www.remedishop.com http://www.herbalpet.com http://www.canagel.com

Follow us:
Facebook @remediplus & @HerbalPetMeds Instagram @remediplus & @herbal_pet Twitter @remediplus & @herbal_pet

 

Tags: , , , , ,
Posted in All Recent Posts | Comments Off on $APPB Applied BioSciences Launches Expanded Pet Line Under Herbal Pet $HTIM

$APPB Applied BioSciences Eagerly Awaiting Hightimes IPO $HTIM

Posted by AGORACOM at 1:26 PM on Wednesday, August 1st, 2018

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png

 

  • Applied BioSciences early stage investment in Hightimes Magazine is valued at approximately $1.75 Million at assumed IPO Pricing of $11.00
  • HTIM anticipates a total raise of $50 million
  • Former Mexican President Vicente Fox set to join High Times Board of Directors
  • Experts predict cannabis industry will grow to $20 Billion by 2020
  • Applied BioSciences is uniquely poised to recieve a return on investment.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact

Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com

Brands:

www.remedishop.com
www.therpet.com

Follow us:

Facebook @remedicbd & @therpetcbd
Instagram @remedicbd & @therpet
Twitter @remedishop & @therpet

FULL DISCLOSURE: AppliedBiosciences is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Medical Marijuana Stocks, Small and Micro-Cap Space | Comments Off on $APPB Applied BioSciences Eagerly Awaiting Hightimes IPO $HTIM